Our analysis revealed an expansion of CD16+ T cells in patients with PCP, an increase in CD57+ CD8+ T cells expressing immune checkpoints, and FCRL5+ B cells in ICI-ILD. The gene discussed is FCRL5; the disease is interstitial lung disease.